Regeneron Pharmaceuticals (REGN) has secured a landmark FDA approval for its monoclonal antibody garetosmab, now commercially known as Pasatru, after more than ten years in development. The drug becomes the second FDA-cleared
Halfords Group plc has set its sights on rejoining the FTSE 250 index following a period of strategic restructuring and improved financial performance. The automotive and cycling retailer, which trades on the
MoreAmgen (AMGN) has teamed up with YouTube megastar MrBeast to raise awareness and funding for pediatric cancer research through a high-profile video campaign. The collaboration was featured in MrBeast’s video titled “I
MoreA newly released second-quarter report on legal technology buying behaviour has found that a dramatic spike in attorney engagement earlier this year was driven by seasonal evaluation cycles. The Q1 2026 surge,
MoreCustom Truck One Source (CTOS) is set to report earnings, with investors and analysts closely watching for signs of operational momentum across its specialised truck and equipment business. The company, which operates
MoreThe week ahead promises significant activity across UK and global markets, with investors closely watching a range of economic indicators and corporate earnings releases. Trading sentiment remains cautious as markets continue to
MoreSanofi (SNY) chief executive Belén Garijo has used her first earnings call as CEO to lay out an ambitious vision for reversing the French pharmaceutical giant’s recent fortunes. Garijo, who previously led
MoreThe U.S. Department of Labor published a Notice of Proposed Rulemaking in the Federal Register on March 27, 2026, targeting the wage methodology used for key visa categories. The proposed rule is
MoreTelehealth company Hims & Hers is facing a fresh legal battle after the Federal Trade Commission filed suit alongside the states of Utah and California. The FTC alleges that Hims & Hers
MoreJersey Mike’s Subs made its public market debut on the New York Stock Exchange, with shares falling and the sandwich chain’s valuation landing at $6.7 billion. The listing marks a significant milestone
MoreSainsbury’s (SBRY) has sold Argos to newly-formed investment vehicle Swift Partners for £120 million, ending a decade of ownership of the struggling catalogue retailer. Swift Partners is led by Richard Pennycook, former
More
